Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Is Clopidogrel a viable first choice P2Y12 inhibitor for DAPT after PCI?

Burden of Disease

DAPT in Elderly with CAD Meta Analysis

Watch the video and get to know more on the crucial insights from this systematic review and meta-analysis of DAPT in elderly patients with acute coronary syndrome (ACS). Dual oral antiplatelet therapy (DAPT) with prasugrel or ticagrelor is associated with a higher risk of bleeding events in elderly patients with ACS compared to clopidogrel, with no difference in primary efficacy endpoint rates between the treatment groups.

Effectiveness and safety of Clopidogrel vs Aspirin

Single Antiplatelet therapy: Insights on earlier use

Rattle

Clopidogrel as the standard of care for elective PCI: Findings from the Alpheus

Understanding de-escalation in Antiplatelet therapy

Management of antithrombotic therapy in patients with AF undergoing PCI

RSV

All Infant Protection

Discover a solution to control mixed Eosinophilic and Allergic Asthma